Sales & Marketing The future is LIVE marketing – and that matters more than ev... Welcome to 2025, world. Think about it: at this same time, just five short years ago, we were in for the ride of our lives, weren’t we?
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.